Get the Daily Brief
Latest Biotech News
FDA approves Regeneron bispecific antibody for multiple myeloma treatment
Regeneron Pharmaceuticals has secured FDA accelerated approval for Linvoseltamab (Lynozyfic), a bispecific antibody targeting BCMA and CD3, for adult patients with relapsed or refractory multiple...
Unnatural Products, Argenx partner on macrocyclic peptides targeting immune diseases
Unnatural Products Inc. has entered a multitarget research collaboration with Argenx SE to develop synthetic oral macrocyclic peptide drugs aimed at ‘undruggable’ immune disease targets. The...
AI-driven drug discovery reveals vorinostat as candidate for Rett syndrome treatment
Researchers at the Wyss Institute leveraged an AI-enabled drug prediction pipeline to identify vorinostat, an HDAC inhibitor approved for lymphoma, as a promising disease-modifying therapy for...
Genomic insights reveal chemotherapy’s mutational impact on healthy blood cells
A comprehensive genomic study by teams from the Wellcome Sanger Institute and University of Cambridge elucidates the distinct mutational signatures left by various chemotherapy agents on normal...
FDA and court actions delay Department of Health and Human Services restructuring
Federal courts in Rhode Island and other jurisdictions have issued preliminary injunctions halting parts of the Trump administration's sweeping Department of Health and Human Services (HHS)...
AI integration accelerates oncology diagnostics and clinical workflows
Adaptive Biotechnologies and Roche's Flatiron Health have partnered to integrate the ClonoSeq minimal residual disease (MRD) assay into Flatiron’s OncoEMR platform, facilitating ordering and...
Breakthrough glioblastoma therapy targets nonmuscle myosin to enhance treatment sensitivity
Researchers have developed MT-125, a nonmuscle myosin II inhibitor that penetrates the brain, effectively reduces glioblastoma invasiveness, and sensitizes resistant tumors to kinase inhibitors...
New machine learning models improve cancer prognosis and diagnostics
Researchers have unveiled advanced AI and machine learning models that enhance early diagnosis and prognosis prediction across various cancers. Notably, radiomics-based CT models differentiate...
Innovations in biomanufacturing accelerate gene and cell therapy production
Bioprocessing platforms are evolving toward modular, flexible, and automated systems to efficiently produce diverse gene-edited therapies at scale. Ori Biotech exemplifies this shift with...
Advances in sustainable materials and environmental biotech for health and agriculture
Recent breakthroughs in sustainable science include development of biodegradable cellulose foams mimicking bread baking, novel 3D-printable bioinks from drought-tolerant sorghum proteins, and gut...
Immunotherapy Advances in Liver Cancer: Dual vs Monotherapy Approaches
Recent clinical studies have highlighted significant progress in immunotherapy for hepatocellular carcinoma (HCC). One multicentric investigation across India confirmed the safety and efficacy of...
Innovations in Glioblastoma Treatment: Targeted Drugs and Microbiome Influence
Glioblastoma remains a formidable brain tumor with limited effective treatments. Researchers have identified new therapeutic candidates such as MT-125, a compound that inhibits non-muscle myosin...
AI and Machine Learning Empower Cancer Diagnosis and Prognosis
Artificial intelligence (AI) is increasingly integrated into oncology for improving early detection and disease management. A new machine learning model developed at the University of Sharjah...
Advancements in 3D Printing and Bioink Materials for Food and Pharmaceuticals
Recent breakthroughs exploit novel material bases for 3D printing applications in food and medicine. Sorghum proteins, known for their drought resistance and hydrophobic properties, have been...
Epigenetics and Molecular Biomarkers in Cancer and Disease
Researchers have identified key molecular markers and mechanisms driving cancer and other diseases. A landmark study detailed the epigenetic diversity in advanced prostate cancer, revealing...
Regulatory and Industry Dynamics Amid HHS Reorganization and Biotech Funding
The U.S. Department of Health and Human Services (HHS) faces legal injunctions halting planned workforce reductions, stemming from lawsuits alleging unauthorized agency restructuring....
Psychedelic Therapies Advance with Positive Clinical Data and Strategic Mergers
Clinical advancements in psychedelic-based treatments are accelerating notably. Beckley Psytech’s intranasal mebufotenin demonstrated significant symptom reductions in treatment-resistant...
Breakthroughs in Oncology: Bispecific Antibodies and Tumor Immunology
Regeneron Pharmaceuticals achieved FDA accelerated approval for Lynozyfic (linvoseltamab), a bispecific antibody targeting BCMA and CD3 in multiple myeloma, marking a significant milestone in...
AI Integration and Innovation in Biomanufacturing and Diagnostic Tools
The incorporation of artificial intelligence (AI) across biomanufacturing and diagnostics is gaining strategic momentum. While regulators like the FDA and EMA explore adaptive frameworks to...
Genomic and Molecular Technology Development for Precision Medicine
Cutting-edge tools in genomics and molecular biology continue to enable transformative advances in medicine. Novel methods for accurate CRISPR off-target prediction have improved with...